{
    "organizations": [],
    "uuid": "71e3701c0bc9fa4b33adfa02034a64a488f44710",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-dova-pharmaceuticals-announces-us/brief-dova-pharmaceuticals-announces-u-s-fda-approval-of-doptelet-idUSASC0A32X",
    "ord_in_thread": 0,
    "title": "BRIEF-Dova Pharmaceuticals Announces U.S. FDA Approval Of Doptelet",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 21 (Reuters) - Dova Pharmaceuticals Inc:\n* DOVA PHARMACEUTICALS ANNOUNCES U.S. FDA APPROVAL OF DOPTELETÂ® (AVATROMBOPAG)\n* DOVA PHARMACEUTICALS INC - POSITIONED TO LAUNCH DOPTELET IN JUNE Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-22T01:03:00.000+03:00",
    "crawled": "2018-05-22T19:18:07.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "dova",
        "pharmaceutical",
        "inc",
        "dova",
        "pharmaceutical",
        "announces",
        "fda",
        "approval",
        "avatrombopag",
        "dova",
        "pharmaceutical",
        "inc",
        "positioned",
        "launch",
        "doptelet",
        "june",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}